Mirae Asset Global Investments Co., Ltd. Sage Therapeutics, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$54.3 Billion
Q1 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 38,568 shares of SAGE stock, worth $415,763. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,568

Previous 36,875 4.59%

Holding current value

$415,763

Previous $799,000 9.64%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$18.62 - $26.95 $31,523 - $45,626	1,693 Added 4.59%	38,568 $722,000
Q4 2023 Jan 24, 2024	SELL	$17.1 - $22.26 $46,306 - $60,280	-2,708 Reduced 6.84%	36,875 $799,000
Q3 2023 Oct 26, 2023	BUY	$16.75 - $48.98 $143,396 - $419,317	8,561 Added 27.6%	39,583 $814,000
Q2 2023 Aug 10, 2023	SELL	$40.65 - $59.54 $67,438 - $98,776	-1,659 Reduced 5.08%	31,022 $1.46 Million
Q1 2023 May 04, 2023	BUY	$37.27 - $46.57 $232,825 - $290,922	6,247 Added 23.63%	32,681 $1.37 Million

Q4 2022 Feb 09, 2023	BUY	$32.2 - $43.61 $740 - $1,003	23 Added 0.09%	26,434 $1.01 Million
Q3 2022 Nov 10, 2022	BUY	$32.28 - $43.27 $322,896 - $432,829	10,003 Added 60.96%	26,411 $1.03 Million
Q2 2022 Jul 26, 2022	BUY	$27.52 - $37.99 $451,548 - $623,339	16,408 New	16,408 $530,000
Q2 2021 Aug 11, 2021	SELL	$54.88 - $79.29 $219,410 - $317,001	-3,998 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$70.65 - $96.76 $57,650 - $78,956	-816 Reduced 16.95%	3,998 $300,000
Q4 2020 Feb 10, 2021	BUY	$58.41 - $89.06 $22,195 - $33,842	380 Added 8.57%	4,814 $417,000
Q3 2020 Nov 12, 2020	BUY	$41.13 - $62.45 $182,370 - $276,903	4,434 New	4,434 $271,000
Q2 2020 Aug 11, 2020	SELL	$25.95 - $43.15 $262,769 - $436,936	-10,126 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$26.15 - $77.24 $77,220 - $228,089	-2,953 Reduced 22.58%	10,126 $291,000
Q4 2019 Feb 12, 2020	BUY	$60.18 - $154.77 $148,945 - $383,055	2,475 Added 23.34%	13,079 $945,000
Q3 2019 Nov 12, 2019	BUY	$140.29 - $189.96 $69,162 - $93,650	493 Added 4.88%	10,604 $1.49 Million
Q2 2019 Aug 13, 2019	BUY	$157.85 - $183.09 $83,186 - $96,488	527 Added 5.5%	10,111 $1.85 Million
Q1 2019 May 13, 2019	BUY	$89.33 - $163.65 $81,111 - $148,594	908 Added 10.47%	9,584 $1.53 Million
Q4 2018 Feb 11, 2019	BUY	$81.94 - $139.71 $19,583 - $33,390	239 Added 2.83%	8,676 $831,000
Q3 2018 Nov 13, 2018	BUY	$138.11 - $169.04 $192,111 - $235,134	1,391 Added 19.74%	8,437 $1.19 Million
Q2 2018 Aug 14, 2018	SELL	$140.36 - $175.76 $3,087 - $3,866	-22 Reduced 0.31%	7,046 $1.1 Million
Q1 2018 May 10, 2018	BUY	$152.15 - $192.33 $170,103 - $215,024	1,118 Added 18.79%	7,068 $1.14 Million
Q4 2017 Feb 12, 2018	BUY	$60.72 - $167.34 $99,459 - $274,102	1,638 Added 37.99%	5,950 $980,000
Q3 2017 Nov 08, 2017	SELL	$61.4 - $88.52 $1.11 Million - $1.59 Million	-18,000 Reduced 80.67%	4,312 $269,000
Q2 2017 Aug 14, 2017	BUY	N/A	22,312	22,312 $1.78 Million

Others Institutions Holding SAGE

# of Institutions

222

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Sage Therapeutics, Inc. Transaction History